The role of Serine Proteases and Serine Protease Inhibitors in the migration of Gonadotropin-Releasing Hormone neurons by Drapkin, Paola T et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Developmental Biology
BMC Developmental Biology  2002,  2 Research article
The role of Serine Proteases and Serine Protease Inhibitors in the 
migration of Gonadotropin-Releasing Hormone neurons
Paola T Drapkin1, Denis Monard2 and Ann-Judith Silverman*3
Address: 1University of Iowa, Iowa City, IA 52242, USA, 2Friedrich Miescher Institut, P.O. Box 2543, CH-4002 Basel, Switzerland and 3Department 
of Anatomy and Cell Biology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA
E-mail: Paola T Drapkin - pdrapkin@blue.weeg.uiowa.edu; Denis Monard - Denis.Monard@fmi.ch; Ann-
Judith Silverman* - as36@columbia.edu
*Corresponding author
Abstract
Background:  Mechanisms regulating neuronal migration during development remain largely
undefined. Extracellular matrix cues, target site released factors, and components of the migratory
neurons themselves are likely all coordinated in time and space directing neurons to their
appropriate locations. We have studied the effects of proteases and their inhibitors on the
extracellular matrix and the consequences to the migration of gonadotropin releasing hormone
(GnRH) neurons in the embryonic chick. Chick GnRH neurons differentiate in the olfactory
epithelium, migrate along the olfactory nerve and enter the forebrain. The accessibility of this
coherent cell group make it amenable for studying protease/inhibitor roles in migratory processes.
Results: Affigel blue beads were used to deliver a serine protease inhibitor, protease nexin-1 (PN-
1), and a target protease, trypsin, to the olfactory epithelium coincident with initiation of GnRH
neuronal migration. PN-1 inhibited neuronal migration while trypsin accelerated their transit into
the CNS. Prior to initiation of migration, neither PN-1 nor trypsin altered the timing of neuronal
exit. Trypsin did, however, accelerate the timing of neuronal crossing into the nerve-forebrain
junction.
Conclusions: These data support the hypothesis that protease activity modulates neuronal
movements across barriers. Moreover, the data suggest, for the first time, that aspects of GnRH
neuronal migration may be cell autonomous but modulated by ECM alterations.
Introduction
A key component regulating neuronal migration is the ap-
propriate spatio-temporal expression of extracellular ma-
trix (ECM) molecules which contribute to the highway
along which neurons travel. Proteins, such as serine pro-
teases and their inhibitors, could alter the quality of this
highway and thus play critical roles in migratory processes
[1]. Members of the serine protease inhibitor superfamily,
or serpins, act by binding to and permanently inactivating
their target protease(s). One member of this family, pro-
tease nexin-1 (PN-1), was first described by Monard et
al.[2]. Though initially characterized for its ability to stim-
ulate neurite outgrowth [2–5], PN-1 also modulates neu-
ronal migration as exemplified by Lindner et al.[6]. Their
studies demonstrate that PN-1 slows granule cell move-
ment from the external to internal layers in postnatal
mouse cerebellar slice cultures.
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Interestingly, this inhibition of migration by protease in-
hibitors may be balanced by the stimulation of migration
via proteases. For example in vitro addition of plasmin, a
serine protease, accelerates the migration of neuroblasto-
ma cells through a matrigel base by a factor of five [7]. The
subsequent addition of aprotinin, a plasmin inhibitor, de-
creases the migratory population to the same degree [8,9].
Furthermore, Seeds et al.[10] demonstrated a retardation
of granule cell migration in tissue plasminogen activator
(tPA) knock-out mice. These data support the hypothesis
that a balance exists between serine proteases and their in-
hibitors such that changes in this balance delay or pro-
mote neuronal migration. The present study was initiated
to test this hypothesis in vivo by examining neuronal mi-
gration of chick gonadotropin releasing hormone (Gn-
RH) neurons during embryogenesis. The site of origin of
these cells in the olfactory placode, as well as the time
course and migratory route along the olfactory nerve
(ON) and into the forebrain are well documented [11–
14]. Previous work in the laboratory has shown that olfac-
tory axons emerge from the olfactory epithelium at stage
18 and are first joined by glia [15] and GnRH neurons
[16] at stage 21.
In order to test whether proteolysis or its inhibition affect
GnRH cellular migration, we performed experiments at
two critical developmental time points. In both of these a
protease or its inhibitor was applied by placing protein-
coated beads at the olfactory placode. The first experi-
ments tested whether application of either of these agents
over the period of stage 21 to stage 29 affected the initial
exit of GnRH neurons from the OE and/or their rate of mi-
gration along the ON and into the CNS. The second exper-
iments tested whether GnRH neurons exited the OE
irrespective of the effects of proteolysis on the maturation
of the olfactory nerve. In this case protein-soaked beads
were applied prior to GnRH exit (stage 17) and the effects
were tested at succeeding stages up to and including their
normal exit time (stages 18, 19, 20, 21). In the latter ex-
periments the effects of proteolysis and its inhibition on
the development of the olfactory nerve itself were tested
using axonal, glial and neuronal outgrowth markers.
These are the first experiments to demonstrate the critical
roles of proteolysis and its inhibition on the regulation of
GnRH cellular migration.
Results
PN-1 and trypsin modulate GnRH neuronal migration in 
vivo during embryogenesis
All embryos analyzed were stage 21 at the time of bead
implantation and stage 29 at the time of fixation. In con-
trol embryos (n = 10) receiving a PB coated bead, GnRH
Figure 1
Sagittal section of a stage 21 chick embryo depicting the implanted bead (B) within the olfactory epithelium (OE). Tissue is
counterstained with cresyl violet. Bead implantation did not disrupt the pseudostratified morphology of the placode epithelium
(arrows). E=eye. Scale bar= 30 µm.BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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neurons in each compartment were counted on the side
ipsilateral and contralateral to the bead. There was no ef-
fect of the bead on GnRH neuronal distribution (Table 1)
or total number (Table 2). Sections counterstained with
cresyl violet revealed no morphological abnormalities of
the epithelium caused by insertion of the bead (Figure 1).
In PN-1 treated embryos, the distribution of GnRH neu-
rons within the olfactory epithelium, nerve and brain on
the side contralateral to the bead and that of controls were
not significantly different indicating that the contralateral
side in experimental embryos served as an internal con-
trol. Therefore, statistical analysis was performed compar-
ing values within embryos (i.e. GnRH neuronal
distribution ipsilateral to the bead was compared to that
contralateral to the bead). Significantly more neurons re-
mained within the epithelium (P < 0.03) and fewer had
crossed into the brain (P < 0.002, see Table 1) on the PN-
1 treated side. The effects of PN-1 on GnRH neuronal dis-
tribution cannot be attributed to changes in total cell
number as there was no difference in this parameter be-
tween groups (Table 2).
Other serine protease inhibitors tested included: soybean
trypsin inhibitor and Type IV chicken ovoinhibitor (data
not shown). These protease inhibitors demonstrated a
range of effects on the distribution of GnRH neurons
across the three compartments. Both concentrations of
soybean trypsin inhibitor tested (1 mg/ml, n = 6 and 10
mg/ml, n = 4) had no significant effect on the distribution
of GnRH neurons. Application of type IV chicken ovoin-
hibitor led to a decrease in the percent of GnRH neurons
remaining in the OE (P < 0.02) and a larger percent within
the telencephalon (P < 0.03).
PN-1 has four known target proteases: urokinase plas-
minogen activator (uPA), tissue type plasminogen activa-
tor (tPA), thrombin and trypsin [17]. Evidence exists for a
role of both trypsin [18,19] and uPA [20,21] in migratory
processes. Therefore, both were tested in our system. All
comparisons made were of the treated side (ipsilateral to
the bead) and the untreated side (contralateral to the
bead).
Trypsin resulted in fewer GnRH neurons within the epi-
thelium (P < 0.008) and along the olfactory nerve (P <
0.04) and more within the brain (P < 0.0001, see Table 1).
There was no significant difference in the total number of
GnRH neurons (Table 2) compared to control. The effect
of trypsin is specific since in embryos receiving a uPA
bead, there was no effect of the protease on the distribu-
tion of GnRH neurons (data not shown).
GnRH neuronal migration is cell autonomous but modulat-
ed by composition of the ECM
As PN-1 can stimulate neurite outgrowth, [2–5] we tested
its effects on outgrowth and maturation of the olfactory
nerve. Maturation of the nerve was followed by immuno-
reactivity to axonal, glial and neuronal markers (summa-
rized in Table 3). All embryos analyzed were stage 17 at
the time of bead implantation and stages 18–21 at the
time of fixation.
Table 1: Per cent of GnRH neurons (+/- standard deviation) in each compartment in embryos implanted with bead at stage 21 and sac-
rificed at stage 29. An asterisk indicates that the bead implanted side was significantly different from the side contralateral to the bead. 
OE, olfactory epithelium; ON, olfactory nerve; TEL, telencephalon.
BEAD SIDE CONTRALATERAL SIDE
Experiment OE ON TEL OE ON TEL
CONTROL N = 10 23+/-6.2 56+/-9.6 20+/-9.1 25+/-10.8 57+/-10.0 18+/-11.0
PN-1 N = 12 * 37+/-14.7 54+/-14.8 * 8+/-8.5 23+/-11.0 59+/-12.5 20+/-13.6
TRYPSIN N = 11 * 21+/-5.8 * 40+/-8.9 * 40+/-8.2 34+/-13.7 50+/-11.9 14+/-7.1
Table 2: Total GnRH neuronal population of embryos implanted 
with a bead at stage 21 and sacrificed at stage 29. There was no 
significant difference in the number of GnRH neurons across 
groups.
Experiment Total cell #
CONTROL 1874+/-554.9
PN-1 1968+/-708.9
TRYPSIN 1461+/-551.6BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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Unilateral insertion of PB coated beads into the olfactory
placode of stage 17 embryos did not disrupt the develop-
ment of either axonal or glial components of the olfactory
nerve between stages 18–21 (Table 3). The time of axonal
outgrowth and sequential acquisition of axonal and glial
markers were identical to that observed previously [15].
The porous nature of the bead was compatible with axon-
al elongation through the mesenchyme towards the devel-
oping telencephalic vesicle. In fact, immunoreactive
axons were found coursing through the bead (Figure 2).
Likewise, there was no alteration in the timing of GnRH
neuronal migration out of the epithelium. At stage 21,
GnRH neurons were found within the olfactory epitheli-
um and along the olfactory nerve (Table 3), a distribution
appropriate for this stage.
Implantation of PN-1 beads did not stimulate premature
olfactory nerve axogenesis. As in controls, very few
MAP1b immunoreactive neurites were present at stage 18
(Table 3). However, PN-1 application did accelerate the
biochemical differentiation of the axons. For instance, un-
der normal conditions, olfactory axons acquire immuno-
reactivity to NCAM at stage 20. In PN-1 treated embryos,
NCAM immunoreactivity was instead present at stage 19.
The sequence of appearance of all markers, however, re-
mained identical to controls. As the length of each devel-
opmental stage varies [22], it is difficult to determine
precisely the amount of time by which biochemical devel-
opment of the axons is accelerated. On average, however,
biochemical differentiation is advanced by 7 hours. Just as
PN-1 did not alter the timing of axogenesis, it also had no
effect on the timing of glial entry into the nerve (stage 21).
Under these conditions, that is, accelerated biochemical
differentiation of olfactory axons, GnRH neuronal distri-
bution was not altered. GnRH neurons were found within
the epithelium and along the nerve and, most important-
ly, none had crossed into the brain.
Implantation of trypsin coated beads at stage 17 had no
effect on either the timing of nerve development (axonal
or glial) or the biochemical differentiation of the axons.
The distribution of GnRH neurons, however, was altered
(Table 3). Under normal conditions, large numbers of
GnRH neurons are within the telencephalon by approxi-
mately stage 25. In the presence of trypsin, however,
GnRH neurons crossed the nerve/brain junction at stage
21, representing a significant acceleration of this event.
Even more significantly, these cells had continued along
their normal migratory path into the presumptive septal
and preoptic areas, their normal target sites.
Figure 2
Sagittal section of a stage 21 chick embryo which received a
PB-coated bead (B) at stage 17. Tissue is processed for
immunocytochemistry using the axonal marker, MAP Ib.
Immunoreactive axonal processes (arrows) extend out of the
epithelium and course through the bead (arrows) towards
the telencephalic vesicle (TEL). Scale bar= 10 µm.
Table 3: Time of appearance of immunoreactivity to axonal, glial and neuronal markers in embryos implanted with a bead at stage 17 
and sacrificed at stages 18–21. The asterisk indicates the appearance of a marker earlier than in controls. OE, olfactory epithelium; ON, 
olfactory nerve; TEL, telencephalon.
MARKER:
Experiment MAP1b NF NCAM PGP9.5 P0 GnRH
CONTROL stage 18 stage 19 stage 20 stage 21 stage 21 stage 21 OE/ON
PN-1 stage 18 * stage 18 * stage 19 * stage 20 stage 21 stage 21 OE/ON
TRYPSIN stage 18 stage 19 stage 20 stage 21 stage 21 stage 21 OE/ON/ TELBMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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Application of uPA beads at stage 17 had no effect on ax-
onogenesis or the nerve's biochemical differentiation or
glial ensheathment. The distribution of GnRH neurons
was likewise not altered (data not shown).
PN-1 and trypsin expression along the GnRH migratory 
route
Endogenous trypsin immunoreactivity was present in the
vast majority of cells within the head of the chick during
the time period studied (stage 21–29). These cells includ-
ed those within the olfactory epithelium and throughout
the mesenchyme as well as axonal tracts within the devel-
oping face, including the olfactory nerve (figure 3, panel
A). To ensure that the immunoreactivity we see in chick is
specific, trypsin protein was pre-adsorbed with the anti-
trypsin antibody. This complex was then used to immu-
nostain chick sections (stages 21–23). No immunoreac-
tivity was evident suggesting that the staining pattern seen
in the chick using the anti-trypsin antibody was specific
(figure 3, panel B). Unlike trypsin, no immunoreactive
uPA was present within regions of the olfactory system or
the developing telencephalic vesicle during this time
frame (data not shown).
Antibodies that recognize chick PN-1 are not available
and thus this protease inhibitor was localized using
mouse embryonic tissue at developmental times corre-
sponding to the chick stages 21–29. Double confocal im-
munofluoresence of mouse tissue (embryonic day 15, El
5) demonstrated that MAP1b immunoreactive axons of
the vomeronasal nerve (VNN), the highway for GnRH
neurons in the mouse [11,13] express PN-1 protein (Fig-
ure 4) but not trypsin (data not shown). Importantly, PN-
1 immunoreactivity was not limited to MAP1b immuno-
reactive axons, but was also present within the basal lam-
inae of the vomeronasal organ (VNO) as well as within
the adjacent mesenchyme (Figure 4). In both El 5 and
adult mouse brains, PN-1 immunoreactivity within the
olfactory bulb was diffuse but appeared to be more con-
centrated within the glomerular layer (data not shown).
S100 positive glia of the VNN express trypsin (Figure 5)
within the cell bodies and along major processes; the dif-
fuse staining suggested it was also in the matrix of the
VNN (Figure 5, 5B). It is clear that PN-1 protein was not
present in the same structures as those immunoreactive
for trypsin (Figure 6) or GnRH (data not shown).
Discussion
This is the first report in which the in vivo application of a
serine protease or its inhibitor have been demonstrated to
affect embryonic neuronal migration. Our data demon-
strate stage specific effects of PN-1 and trypsin on the dis-
Figure 3
Sagittal section of stage 21 chick embryo immunostained
with an anti-trypsin antibody. The olfactory nerve (ON,
arrow) was immunoreactive for trypsin as were regions of
the developing telencephalon (TEL). As a control, typsin pro-
tein was incubated with the anti-trypsin antibody for pre-
absorption. This antigen/antibody complex was then used to
immunostain sagittal sections of stage 21 chicks. Panel B
demonstrates that pre-absorption eliminated all immunore-
activity in the head demonstrating the specificity of trypsin
immunolocalization in experimental sections.
Figure 4
A 1 µm optical section of an El 5 mouse embryo cut in the
sagittal plane at the level of the vomeronasal organ (VNO).
MAP1b immunoreactive axonal bundles (A, arrows) of the
vomeronasal nerve are identified by FITC fluorescence; PN-1
immunoreactivity (B, arrows) by Texas Red fluorescence. All
fascicles were double labeled. Scale bar= 100 µm.BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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tribution of chick GnRH neurons along their migratory
route, without an alteration of their total population.
Stage specific introduction of these proteins was via uni-
lateral insertion (into either the olfactory epithelium or
placode) of protein coated Affigel Blue beads. The use of
these beads is an established method widely utilized to
deliver exogenous proteins during development. For ex-
ample, in their study of limb development, Fallon et
al.[23] demonstrated depletion of iodinated FGF protein
from Affigel Blue beads indicating protein does indeed
diffuse out of the bead. In fact, the authors demonstrated
that approximately half the iodinated protein diffused off
the bead within the first 24 hours and 70% diffused by ap-
proximately 60 hours. These data indicate that protein is
present and diffusing into the surrounding area up to 60
hours following implantation of the bead. Our experi-
ments were carried out within this window of time (there
are 24 hours between stage 17 to 21 and 60 hours between
stage 21 and 29). In addition, subsequent studies examin-
ing the roles of BMP, FGF's and Shh have also utilized Af-
figel Blue beads to exogenously introduce various protein
components [24,25]. The results of these studies have
been consistent with the known temporal and spatial dis-
tributions of these proteins.
Modification of the extracellular milieu via local shifts in
the protease/inhibitor balance may regulate neuronal mi-
gration. This hypothesis is supported by our findings on
stage 21–29 embryos. In these experiments, inhibition of
endogenous trypsin-like activity by PN-1 resulted in fewer
GnRH neurons exiting the olfactory epithelium and a cor-
responding decrease in the number entering the brain.
Conversely, increasing trypsin availability promoted neu-
ronal crossing of these two boundary zones. We hypothe-
size that the serine protease/inhibitor pair act by altering
the ECM through which GnRH neurons migrate. Matrix
involvement in migration is supported by the identifica-
tion of matrix components throughout the GnRH migra-
tory route. At the epithelium, GnRH neurons cross the
Figure 5
A confocal image of fascicles of the El 5 mouse embryo
vomeronasal nerve prior to its penetration into the telen-
cephalon. S100 immunoreactive glial cells which ensheath the
nerve (FITC, A) colocalize with trypsin immunoreactivity
(Texas Red, arrowheads delineating staining) of the vomero-
nasal nerve. Arrows point to glial cell bodies or their proc-
esses. C. This co-localization is best seen in an overlay where
the double labeled glial cell bodies and their processes are
yellow (double arrows). There is also red fluorescence
external to the glia, most likely in the extracellular matrix.
Scale bar= 100 µm.
Figure 6
A lµm optical section of an El 5 mouse embryo cut in the sag-
ittal plane at the level of the vomeronasal organ (VNO). A.
PN-1 was localized using Texas Red fluorescence. Immuno-
reactive sensory cells (arrowheads) were found occassionally
which supports the co-localization of this protein in vomero-
nasal nerve axon bundles (Figure 1). PN-1 is also concen-
trated in the basal laminae (arrow) and displays a meshwork
pattern in the nerve. B. Trypsin was identified by FITC fluo-
rescence. Trypsin staining forms a fine meshwork within the
VNO. Note that sensory cell in A. (arrowhead) is not posi-
tive for trypsin. The staining pattern for trypsin suggests it
also has an extracellular localization. There is no co-localiza-
tion of PN-1 and trypsin proteins. Scale bar= 100 µm.BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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basal laminae to initiate their migratory phase [15]. The
olfactory nerve expresses several matrix molecules
[heparan and keratan sulfate proteoglycans [26], laminin
[27], phosphocan [28], lectin-binding domains [29]]. Any
or all of these may serve as substrates for proteolysis. The
three domains, the olfactory epithelium, olfactory nerve
and the brain, represent regulatory road blocks to the
GnRH cell. By inhibiting local proteolysis, PN-1 produces
a non-conducive environment at these points. Likewise,
promotion of local proteolysis by trypsin, results in a per-
missive migratory environment.
Though modification of the ECM composition may in-
deed explain the data, another explanation may lie in the
activation/inhibition of protease activated receptors
(PAR's). These two hypotheses are not mutually exclusive
but rather may work in concert to regulate neuronal mi-
gration. PAR'S are G-coupled receptors activated by prote-
olytic cleavage of their exo-domains. This cleavage
exposes an amino acid sequence which then serves as a
tethered ligand activating transmembrane signaling. Four
PAR'S have been identified (PAR 1–4); PAR'S 1,3 and 4 are
activated by thrombin while PAR2 is activated by trypsin
[30]. Activation of PAR'S may alter ECM composition. For
example, Hattori et al.[31] demonstrated that thrombin
activation of PAR1 led to deposition of P-selectin, a leuko-
cyte adhesion molecule, on the surfaces of endothelial
cells. This change in matrix composition allows for leuko-
cyte attachment and subsequent infiltration of the en-
dothelium. PAR'S are expressed in the developing rat CNS
[32] as well as in the embryonic chick [33]. Though we did
not localize PAR expression in our model system, it re-
mains a possibility that their activation or inhibition may
modulate the ECM composition and thus GnRH neuronal
migration.
The fact that mammalian PN-1 alters neuronal migration
in an avian species suggests the presence of endogenous
serine protease activity in the region. Such a protease, with
trypsin-like immunoreactivity, was detected by immuno-
cytochemistry. To biochemically characterize this endog-
enous activity, non-neurally derived trypsin inhibitors
were tested. At the concentrations tested, soybean trypsin
inhibitor had no effect on GnRH migration. These results
could be due to differences in binding affinity between
soybean trypsin inhibitor and PN-1 for the endogenous
trypsin-like molecule. The inhibition of trypsin-like pro-
teases by different inhibitors (including PN-1 and soy-
bean trypsin inhibitor) varies widely and a lack of an
effect is not uncommon (e.g. 34).
Contrary to the effect seen with PN-1, type IV chick ovoin-
hibitor accelerated neuronal migration with fewer GnRH
neurons in the epithelium and correspondingly more
within the brain. At least two mechanisms can explain this
result. First, type IV chick ovoinhibitor may not be acting
as an inhibitor in our system as it has been demonstrated
to be ineffective in other systems [34–36]. Alternatively, if
it is serving as a protease inhibitor, it may inactivate a
molecule different from that affected by PN-1 and, in do-
ing so, generate an environment permissive for neuronal
migration.
Both non-neuronally derived trypsin inhibitors tested
yielded results different from that of PN-1 suggesting they
possess different protease specificities, affinities, or func-
tions. Regardless of their mechanisms of action, these data
support the hypothesis that changes in enzymatic activi-
ties can influence neuronal migration.
In contrast to PN-1, trypsin leads to a permissive environ-
ment during this developmental period (stages 21–29) re-
sulting in a global acceleration of GnRH neuronal
migration out of the olfactory epithelium and into the
brain. Trypsin cleaves peptide bonds at the carboxyl side
of either arginine or lysine residues. This rather non-spe-
cific cleavage suggests trypsin may alter many different
components of the ECM which themselves vary in each
compartment. Interestingly, in the chick, trypsin immu-
noreactivity was present throughout the head as well as in
the olfactory nerve. This ubiquitous distribution suggests
that the specificity of the protease/inhibitor system may
be imparted by an avian equivalent of PN-1.
We found no effect on GnRH neuronal distribution in
uPA-treated embryos and no uPA immunoreactivity. This
result is not surprising in light of a study by Del Bigio et
al.[37] in which the expression pattern of uPA was ana-
lyzed in the postnatal mouse. Based on its spatio-tempo-
ral expression pattern, the authors concluded that uPA
may function in processes of synaptogenesis and remode-
ling rather than in cell migration. In addition, our data in-
dicate that simply coating beads with any serine protease
is not sufficient to influence migration. Thus, not only is
our experimental approach unbiased, but the antagonistic
relationship of PN-1 and trypsin on GnRH neuronal mi-
gration is specific.
A PN-1 specific antibody that cross reacts with chick tissue
is not available, thus we were unable to follow its expres-
sion in the chick. Although avian and mammalian serpins
are members of the same superfamily, they are evolution-
arily distinct [38]. This divergence likely accounts for the
species specificity of the PN-1 antibody. To determine
whether PN-1 is expressed by the olfactory system during
the time of active GnRH neuronal migration, we exam-
ined its expression in the embryonic mouse where its
mRNA is known to be expressed [39]. At E15, PN-1 pro-
tein is present within MAP1b immunoreactive axons of
the vomeronasal nerve (the migratory path used by GnRHBMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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neurons in mammals). PN-1 immunoreactivity was also
present within the basal laminae of the vomeronasal or-
gan, a barrier crossed by GnRH neurons when they initiate
their migration. This staining pattern, along with our data
on PN-1's effect on migration, strengthens our hypothesis
that this serine protease inhibitor plays a role in neuronal
migration. In addition, expression of other serine protease
inhibitors has been described in other migrating neurons.
For example, Krueger et al.[40] demonstrated increased
expression of neuroserpin within migrating granule cells
of the cerebellum in the post natal mouse.
In the mouse, trypsin immunoreactivity is present within
S 100 immunoreactive glia which ensheath axons of the
vomeronasal nerve. As with PN-1, it is also present in the
extracellular matrix where it is likely that the protease/in-
hibitor pair function to regulate, at least in part, the envi-
ronment through which GnRH neurons migrate.
Due to its ability to stimulate neurite outgrowth, we asked
whether PN-1 could alter the timing of formation of the
olfactory nerve and if so, what effect this might have on
GnRH neuronal migration. For these experiments, bead
implantation into the olfactory placode was performed at
stage 17 just prior to olfactory nerve axonogenesis. PN-1
did not accelerate neurite outgrowth but did accelerate de-
tectable levels of biochemical differentiation markers of
the olfactory nerve. These data suggest that the olfactory
neurons can respond to PN-1 directly or to changes in the
local environment caused by PN-1.
The distribution of GnRH neurons was not altered by PN-
1 at stages 17–21 in spite of the accelerated maturation of
the olfactory nerve. Likewise, PN-1 did not alter the tim-
ing of the nerve's ensheathment by glia. This suggests that
glial migration is independent of any matrix changes in-
duced by PN-1. The fact that GnRH neurons and the glial
ensheathing cells exit at the same time (stage 21) may be
coincidental or may be due to an interaction between
these two populations. Alternatively, the timing of exit of
GnRH neurons and glia may be cell-autonomous events.
Implantation of a trypsin bead at stage 17 had no effect on
the biochemical maturation of the olfactory nerve nor on
the timing of glial or GnRH neuronal migration. At this
early stage, at least some of the barriers to GnRH neuronal
exit from the epithelium are in place [15]. Therefore, the
lack of an effect on migration by trypsin suggests that the
initiation of migration is an inherent property of the
GnRH neuron (and glial cell). At stage 21, however,
trypsin did significantly alter the distribution of GnRH
neurons such that a large population was already in the
brain. These neurons not only entered the brain early but
also traveled caudalward within the brain along their nor-
mal arching trajectory.
Taken together, these data suggest that in the presence of
either trypsin or PN-1 (at stage 17), GnRH neurons exit
the olfactory epithelium at stage 21, as in controls. There-
fore, the ability to initiate migration resides within the
neuron itself such that alterations of ECM composition
during this time (stage 17–21) are irrelevant to the timing
of this initial event. The finding that the neurons enter the
CNS early in trypsin-treated embryos suggests that contin-
ued movement may be a cell autonomous event with
trypsin-induced proteolysis generating a permissive envi-
ronment. Finally, these data demonstrate that the GnRH
neuron's ability to transit across the glia limitans and
through the brain to its target sites is independent of ad-
ditional maturation of the neuron itself, the olfactory
nerve or the brain.
Our data support a role of proteases and their inhibitors
in neuronal migration. The complex interactions between
a neuron and its environment are likely not regulated by
proteolysis alone. The characteristic directed migratory
pattern taken by the GnRH neuron and the cohesiveness
of the population suggests a more complex system is in
place to ensure their appropriate translocation into the
brain. In fact, Kramer and Wray [42] have identified a nov-
el gene, nasal embryonic LHRH (GnRH) factor or NELF,
which is expressed by GnRH neurons during their migra-
tory phase and olfactory sensory neurons as they initiate
axonogenesis. Antisense depletion of NELF led to a de-
crease in both olfactory axonal outgrowth and the
number of GnRH neurons exiting the epithelium. The au-
thors suggest that NEFL may function as a migratory fac-
tor. It seems likely therefore that several components
interact to orchestrate the proper migration of neurons.
Materials and Methods
Animal and tissue preparation
Chicks
Fertilized eggs (white leghorn, SPAFAS, Preston, CT) were
placed in an incubator (Humidaire Incubator, Co. New
Madison, OH) at 99.5°C and 85% relative humidity. A
window was cut in each shell to determine the develop-
mental stage of each embryo [22]. To visualize the extrae-
mbryonic membranes, Fast Green (1:10,000 Molecular
Probes, Eugene, OR) was applied to the surface of the em-
bryo and membranes were teased apart using forceps. Ap-
propriately sized Affigel Blue beads (BioRad, Hercules,
CA) were unilaterally inserted either into the olfactory
placode (stage 17) or the olfactory epithelium (stage 21)
and the egg was returned to the incubator until time of fix-
ation. Control animals were implanted with beads coated
with 0.1 M phosphate buffer, pH 7.3 (PB, N = 10). Exper-
imental embryos were implanted with beads coated with
PN-1 bead (N = 12) or trypsin (N = 11). Embryos receiv-
ing a bead at stage 17 were fixed at stage 18 (N = 9), stage
19 (N = 16), stage 20 (N = 17) or stage 21 (N = 9). Embry-BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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os receiving a bead at stage 21, were fixed at stage 29 (N =
10).
Embryos were fixed by immersion in 4% paraformalde-
hyde (Fisher Scientific, Pittsburgh, PA) for 1–7 days de-
pending on the stage (younger embryos required shorter
fixation times). Fixed embryos were embedded in 8% gel-
atin and fixed in 4% paraformaldehyde. 100 µm sagittal
sections were cut on a vibratome (DSK Microslicer 1500E,
Ted Pella, Inc., Redding, CA) and immunocytochemistry
was performed on free-floating sections. Tissue was then
mounted onto slides, dehydrated through graded alco-
hols, cleared with HemoD (Fisher) and coverslipped with
Permount (Fisher).
Mice
As reagents for the localization of PN-1 in the chick are
not available, we examined its localization in the embry-
onic mouse at the time of GnRH migration. Immunolo-
calization of PN-1 protein was performed on embryonic
day 15 (El 5, day of plug was considered E0.5). Swiss Web-
ster mice were used (Charles River, Kingston, MA). Mouse
embryos (N = 6) and an adult female (N = 1) were proc-
essed for double label immunofluorescence to determine
the cellular localization of PN-1 and trypsin. The mothers
were euthenized with CO2 and embryos placed in PB and
decapitated rapidly. The adult was anesthetized with nem-
butal (70 mg/kg) and perfused transcardially. Tissue was
treated as described above.
Anesthesia, Surgery, and Perfusion
All procedures for the mice met with NIH guidelines and
were approved by the Institutional Animal Care and Use
Committee of Columbia University.
Affigel-Blue bead preparation
Affigel Blue beads (BioRad, Hercules, CA) were sized us-
ing a dissecting microscope and forceps as described by
Vogel et al.[41]. Beads 30–50 µm in diameter were used
for stage 21 embryos and beads 20 µm in diameter were
used for stage 17 embryos to accommodate the smaller
target area. Beads were placed in one of the following so-
lutions: 3.1 mg/ml of recombinant rat PN-1; 2.3 mg/ml of
trypsin (type III bovine pancreas, Sigma, St. Louis, MO); 1
mg/ml urokinase plasminogen activator (uPA, Sigma, St
Louis, MO); 1 or 10 mg/ml soybean trypsin inhibitor (Sig-
ma, St Louis, MO); 10 mg/ml type IV chick egg white pu-
rified ovoinhibitor (Sigma, St Louis, MO) at 4°C
overnight and used the next day. Control beads were
soaked in PB overnight at 4°C and used the next day.
Free floating immunocytochemistry
Single label
Tissue was washed and treated with 0.5% hydrogen perox-
ide to remove endogenous peroxidase activity. Following
an overnight incubation in 0.1% Triton X-100 (Tx100,
Sigma, St Louis, MO) containing 3% normal goat serum
in PB at 4°C, sections were incubated in rabbit polyclonal
anti-GnRH antibody (SW-1, 1:5000 in 0.1% Tx100 in PB,
generously provided by Dr. S. Wray, NIH) for at least 4
days at 4°C. Following three PB washes, tissue was then
incubated in biotinylated goat-anti-rabbit-IgG (1:200,
Vector Labs, Burlingame, CA) in 0.1% Tx100 in PB over-
night at 4°C. The following day, sections were washed in
PB and incubated in avidin-biotin-HRP complex (1:200,
Vector Labs, Burlingane, CA) for at least 3 hours at room
temperature. After PB washes, bound antibody was detect-
ed using 3,3'-diaminobenzidine (DAB, Sigma, St Louis,
MO) as the chromogen.
Brains processed for immunocytochemical localization of
protease, PN-1 or axonal/glial markers were treated as de-
scribed above, however the primary antibodies used were
specific for each protein (see list below). Sections were
viewed and photographed with an Olympus Vanox mi-
croscope (New York/New Jersey Scientific Inc., Middle-
bush, NJ).
Double label
Brains processed for double label immunofluorescence
were treated as described above. The first antibody was de-
tected using the appropriate biotinylated IgG followed by
avidin-fluorophore (either Texas Red or FITC, Sigma, St
Louis, MO), while the second antibody was detected by a
directly conjugated IgG-fluorphore. All fluorescent images
were acquired with a Zeiss confocal microscope using
LSM 410. Images were acquired at 40 or 100X using 16 av-
eraged scans at 1028 ×  1028 pixel resolution and printed
using Adobe Photoshop IV.
Control
To test the specificity of the method, tissue was processed
as described above for the first antibody. In the second set
of reactions, 3% normal mouse serum (Vector Labs, Burl-
ingane, CA) in 0.1% Tx100 in PB was substituted for the
primary antibody. This was followed by horse anti-mouse
IgG-FITC. Under these conditions, no FITC immunofluo-
rescence was detected. As an additional control for trypsin
immunoreactivity in the CNS, trypsin protein was incu-
bated with the anti-trypsin antibody for 4 hours at 4°C for
antibody adsorption. This antigen/antibody complex was
then utilized to immunostain chick tissue sections; no im-
munoreactivity was detected (see figure 3).
Antibodies/antisera and dilutions
Axonal markers
NCAM: A mouse monoclonal antibody raised against the
highly sialylated embryonic forms of the neural cell adhe-
sion molecule was used (1:1, Developmental Studies Hy-
bridoma Bank).BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/1
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NF: Two mouse monoclonal antibodies raised against the
heavy (200 kD) and light (68 kD) forms of neurofilament
were used (1:200 each, Sigma, St Louis, MO). Both anti-
bodies recognize phosphorylated variants of neurofila-
ment.
MAP1b: A mouse monoclonal antibody to the microtu-
bule associated protein 1b was generously provided by
Dr. Lester Binder, University of Alabama at Birmingham.
The antibody was used at 1:1000 and was selected because
MAP1b is the earliest expressed MAP both in vivo and in
vitro[43].
PGP9.5: A rabbit polyclonal antibody raised against hu-
man protein gene product 9.5 was used at 1:1000 (Bio-
genesis, Ltd,. Poole, England). This is a neuron-specific
ubiquitin carboxy terminal hydrolase.
Glial markers
P0: A mouse monoclonal antibody, 1E8, raised against the
mammalian myelin protein, P0, was used at 1:4000 and
was generously provided by Dr. R. Brackenbury (Universi-
ty of Cincinnati, Cincinnati, OH). This antibody recogniz-
es Schwann and ensheathing cells of the olfactory nerve
but not astrocytes.
MAP4: A mouse monoclonal antibody raised against mi-
crotubule associated protein 4, MAP4, was generously
provided by Dr. Chloe Bulinski (Columbia University,
NY, NY) and used at 1:1000. MAP4 is the major MAP ex-
pressed by non-neuronal tissue.
S100: A rabbit polyclonal anti-S100 antibody was used at
1:1000 (Biogenesis, Ltd, Poole, England). S 100 is a cen-
tral and peripheral glial cell marker.
GnRHmarker
GnRH: a polyclonal antibody raised against GnRH conju-
gated with glutaraldehyde to ovalbumin was generously
provided by Dr. Susan Wray (NIH). This antibody recog-
nizes amino acids: 3,4,7,8,9, and 10 of the GnRH peptide
and was used at 1:5000.
Protease antibodies
Trypsin: An anti-human cationic trypsin antibody was
used at 1:1000 (Biodesign, Kennebunk, ME).
uPA: An anti-uPA antibody was used at 1:1000 (Accurate
Chemical, Westbury, NY).
Protease inhibitor antibody
PN-1: An anti-rat PN-1 antibody was used at 1:500 and
was generously provided by Dr. D. Monard (Friedrich Mi-
escher Institut, Basel, Switzerland).
Coagulation Assay
To ensure that the proteases and inhibitors used were ac-
tive, a coagulation assay was performed. Blood alone
(from PD) coagulated in approximately 2 minutes. Incu-
bation of blood with 1 mg/ml uPA delayed coagulation
significantly (by several minutes). Incubation with com-
bined PN-1 and uPA resulted in rapid coagulation as in
control.
Cell counts and statistical analysis
Cell counts for PN-1 and serine proteases were performed
by PD who was unaware of the experimental status of the
embryos. Those for the other serine protease inhibitors
were carried out by a second observer (XLZ). Both observ-
ers carried out independent counts on separately prepared
sets of PB controls. An equal number of immunoreactive
tissue sections was counted for each side of the face (i.e.
the side containing the bead and the contralateral side).
Selected sections were recounted by AJS to check for accu-
racy. Cell number was determined via a modified optical
dissector method [44–46]. Examination of tissue reveals
three focal planes; the nucleus being in crisp focus in only
one of these planes. This profile allows cells (nuclei) to be
counted in each of the three planes. Double counting is
avoided for those cells in the top and bottom planes by
counting alternate sections.
Immunoreactive GnRH neurons separated into categories
depending on location: olfactory epithelium (OE), olfac-
tory nerve (ON) and telencephalon (CNS). Numbers in
each category were then expressed as a percent of total
number of GnRH neurons on that side of the face. The
contralateral side served as a within animal control. To an-
alyze for significant differences in percentage of GnRH
neurons in each category, an unpaired students t-test (p <
0.05) was performed.
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